Navigation Links
Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
Date:5/24/2008

VANCOUVER, May 24 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced that June 26, 2008 has been set as the date for the Annual Stockholders Meeting.

The Annual Meeting of Dragon stockholders will be held at Suite 2808, International Chamber of Commerce Tower, Fuhua Three Road, Shenzhen, China at 2:00 p.m. local time. Stockholders of record as of the close of business on May 26, 2008 will be entitled to vote on the election of directors.

On or about May 30, 2008, the Company will send to these stockholders a copy of the proxy statement in connection to the Annual Meeting.

CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, COO, Telephone: (604) 669-8817, or North America Toll Free: 1-877-388-3784, Email: irdragon@dragonpharma.com, Website: http://www.dragonpharma.com


'/>"/>
SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
2. Dragon Pharma announces 2007 full year financial results
3. Dragon retains leading investor relations firm
4. Dragon announces new product launch; increase in annual production output capacity
5. Dragon Announces R&D Achievement in Biotech Manufacturing Process
6. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
9. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
10. Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry
11. VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... Proove Biosciences, Inc. , the commercial and ... McGill University . The partnership is designed to advance research in pain genetics ... patients in pain. With the new agreement, researchers at Proove Biosciences are able to ...
(Date:5/4/2016)... According to a new market ... Global Industry Analysis, Size, Share, Growth, Trends, and Forecast ... expand at a CAGR of 17.1% from 2016 to ... Metabolomics is the extensive study of small molecules, ... organisms. Together, these small molecules and their interactions in ...
(Date:5/3/2016)... PUNE, India , May 3, 2016 ... Type (DNA Chip (Genomics, Drug Discovery, Gene ... Chips), End user (Academics Institutes, Diagnostics Centers), ... 2020" published by MarketsandMarkets, the market is ... 2020 from USD 7.63 Billion in 2015, ...
(Date:5/3/2016)... ... 03, 2016 , ... Leading CEOs from biotech, pharmaceutical, and ... June 1st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
Breaking Biology Technology:
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:3/31/2016)... RATON, Florida , March 31, 2016 ... LEGX ) ("LegacyXChange" or the "Company") ... for potential users of its soon to be launched ... video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide ... the use of DNA technology to an industry that ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):